RemeGen荣昌生物 Alternatives & Competitors

12 companies similar to RemeGen荣昌生物 — 用科学提高生命质量

Recordati

Recordati. Unlocking the full potential of life.

4223 IPO $600.00M

Milan, Italy

E-Commerce Internet

Gilead Sciences

Creating Possible

14730

Foster City, United State...

Health Care Pharmaceutical +1

Zydus Group

Driven by a passion for innovation, making a difference in the world of healthcare

20482 Post Ipo Equity $7.00M

Ahmedabad, India

Health Care

OMEICOS Therapeutics GmbH

Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty...

10 Series C $36.38M

Berlin, Germany

Track all RemeGen荣昌生物 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Gracell Biotechnologies

A Member of the AstraZeneca Group

33 Acquired $1.29B

Shanghai, China

Biotechnology Health Care

Verge Genomics

Better drugs, faster. For patients who can’t wait.

28 Series B $134.00M

South San Francisco, Unit...

Biotechnology Health Care +1

Aro Biotherapeutics

51 Series B $166.50M

Philadelphia, United Stat...

Biotechnology Health Care +2

士泽生物医药

病人第一，刀锋第二，股东第三

3 Series A $77.00M

China

Biopharma Biotechnology +1

CRISPR Therapeutics

Gene-based medicines for patients with serious diseases

350 IPO $1.05B

Boston, United States

Biopharma Biotechnology

Mozart Therapeutics, Inc.

Orchestrating the Immune System

36 Series A $80.00M

Seattle, United States

Biotechnology

Actio Biosciences, Inc.

From One To Many.

41 Series A $55.00M

San Diego, United States

Biotechnology Clean Energy

Nitrase Therapeutics

Pioneering Nitrase Biology and Medicines

13 Series A $45.10M

Brisbane, United States

Biotechnology Health Care +1

About RemeGen荣昌生物

用科学提高生命质量

Services

Drug Discovery, Research and Development, Biological Medicine Manufacturing, Clinical Trial Conducting, New Drug Market Launch

Target Customers

Patients with Major Diseases, Healthcare Providers, Medical Institutions, Pharmaceutical Distributors

Taxonomy

Biologics, Biotech Innovation, Therapeutic Innovation, Cancer Treatment, Autoimmune Disease Therapy, Eye Disease Treatment, Biopharmaceutical Industry, ADC (Antibody-Drug Conjugates), Biological Drugs, Clinical Studies, Drug Development, Unmet Clinical Needs, Global Commercialization, Scientific Research Investment, Differentiated Drugs

Business Model

B2B, B2C, D2C

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to RemeGen荣昌生物 include Recordati, Gilead Sciences, Zydus Group, OMEICOS Therapeutics GmbH, Gracell Biotechnologies. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to RemeGen荣昌生物 based on industry overlap, target customers, and business model.

用科学提高生命质量

Don't just read about them. Follow them.

BounceWatch watches RemeGen荣昌生物 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

RemeGen荣昌生物 Profile Recordati Alternatives Gilead Sciences Alternatives Zydus Group Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at RemeGen荣昌生物 on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.